Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

NCT03486223 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
PreDiabetes
Obesity

Interventions

DRUG: GSK2256294
DRUG: Placebo oral capsule

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]